Clover Health Investments Corp - SIC # 7372 - PREPACKAGED SOFTWARE

Ticker Exchange SIC # Website Latest Ticker
CLOV Nasdaq 7372 https://www.cloverhealth.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Clover Health Investments Corp

Clover Health to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023 - Jan 30th, 2023 9:05 pm
Clover Health Provides Business Update and Issues Partial Guidance for Full-Year 2023 - Jan 10th, 2023 2:15 pm
Clover Health to Present at 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023 - Jan 4th, 2023 9:05 pm
Clover Health Issues December 2022 Investor Frequently Asked Questions - Dec 13th, 2022 9:30 pm
Dr. Anna Loengard Joins Clover Health Board of Directors - Nov 30th, 2022 9:05 pm
Clover Health Reports Third Quarter 2022 Financial Results - Nov 7th, 2022 9:05 pm
Clover Health to Present at Credit Suisse 31st Annual Healthcare Conference on November 10, 2022 - Nov 3rd, 2022 8:05 pm
Clover Health Medicare Advantage Plans Earn 3.5 Star Rating for 2023 - Oct 11th, 2022 8:05 pm
Clover Health to Report Third Quarter 2022 Financial Results on November 7, 2022 - Oct 10th, 2022 8:05 pm
Clover Health Debuts New Medicare Advantage Plans for 2023 - Oct 6th, 2022 8:05 pm
Clover Health to Present at 2022 Wells Fargo Healthcare Conference on September 7, 2022 - Aug 31st, 2022 8:05 pm
Medicare enrollees to see Inflation Reduction Act benefits ‘very soon,’ health official says - Aug 22nd, 2022 7:56 pm
Clover Health Reports Second Quarter 2022 Financial Results - Aug 8th, 2022 8:08 pm
Clover Health Announces Evolution of Leadership Roles to Best Support Future Growth - Aug 8th, 2022 8:06 pm
Clover Health to Present at Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022 - Aug 3rd, 2022 8:05 pm
Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Jul 26th, 2022 8:43 pm
Dr. Carladenise Armbrister Edwards Joins Clover Health Board of Directors - Jul 26th, 2022 8:05 pm
Who are the Financial Leaders of Tomorrow? - Jul 18th, 2022 10:32 pm
Clover Health Announces Planned Medicare Advantage Expansion for 2023 - Jul 14th, 2022 8:05 pm
Clover Health to Report Second Quarter 2022 Financial Results on August 8, 2022 - Jul 11th, 2022 8:05 pm